GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytesS. Tuuli Karhu, Heikki Ruskoaho|Archives of Toxicology|2020Cited by 30